Urgent.News

What's breaking now, across thousands of outlets.

Business

Daimler Truck steigert Gewinn im dritten Quartal um 73 Prozent

Die positive Entwicklung wird auf eine sich erholende Marktlage zurückgeführt

Original German Read in English

Daimler Truck, the world's largest commercial vehicle manufacturer, has benefited from US customs refunds, boosting its earnings by 73 percent in the third quarter. In its latest quarterly report, the DAX company disclosed a refund claim amounting to a "low three-digit million euro figure", significantly contributing to the profit increase.

The company reported EBIT of 1.1 billion euros, a 73 percent rise compared to the previous year. However, on a nine-month basis, the profit was ten percent below the same period last year. Daimler Truck manufactures vehicles for the North American market in the US and Mexico. Since November 2025, an additional tax of 25 percent has been imposed on imports from Mexico into the US.

In April 2025, the US Supreme Court ruled that a significant portion of the tariffs imposed by then-President Donald Trump were unlawful. Daimler Truck receives refunds for vehicles assembled in Mexico using US components. The German automaker had previously been granted permission by the US Trade Ministry to recognize US value-added proportions in April 2025.

These are calculated in a complex procedure and converted back into refunds. Additionally, there are various types of customs duties that Daimler Truck must pay but will now receive in return.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at derstandard.at →

More in Business

Metavia Reports DA-1726 Cuts Liver Fat

Metavia, an affiliate of Dong-A ST, announced interim analysis results from Part 3B of the Phase 1 clinical trial of DA-1726 at the Precision Liver Symposium 2026 held in Denver, the United States, on…

  • DA-1726 reduces liver fat by 68% in obese adults over 16 weeks
  • 83% of treatment group patients achieve >30% liver fat reduction
  • Glycated hemoglobin (HbA1c) improves by 0.44 percentage points

More from Friday 6 November →